Nexalis Therapeutics Limited has released a press release.
Private Placement and Market update
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Voluntary Suspension
- Private Placement Successfully Completed to raise $300,000
- Licence Agreement with Jayex Healthcare
- Response to ASX Price Query
- Pause in trading
Later from Nexalis Therapeutics
- CEO appointment
- Quarter 3 Update
- $720,500 Private Placement
- Non-renounceable rights issue
- Rights Issue Offer Document
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics